ARCOPINTO, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 1.437
EU - Europa 837
AS - Asia 476
AF - Africa 47
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.808
Nazione #
US - Stati Uniti d'America 1.404
IT - Italia 447
SG - Singapore 256
CN - Cina 159
NL - Olanda 105
UA - Ucraina 103
DE - Germania 46
CI - Costa d'Avorio 43
IE - Irlanda 34
CA - Canada 33
FR - Francia 32
IN - India 32
FI - Finlandia 29
VN - Vietnam 12
CZ - Repubblica Ceca 11
SE - Svezia 10
ID - Indonesia 7
GB - Regno Unito 6
AR - Argentina 4
EG - Egitto 4
HK - Hong Kong 3
SI - Slovenia 3
CO - Colombia 2
EC - Ecuador 2
GR - Grecia 2
LU - Lussemburgo 2
TH - Thailandia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
BR - Brasile 1
EE - Estonia 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
Totale 2.808
Città #
Chandler 281
Singapore 218
Ashburn 117
Naples 108
Amsterdam 103
Millbury 89
Santa Clara 55
Beijing 52
Des Moines 49
Napoli 49
Princeton 37
Nanjing 33
Lawrence 29
Ottawa 27
Pune 24
Rome 19
Boston 16
Salerno 15
Wilmington 14
Milan 13
Dong Ket 12
Seattle 12
Jiaxing 11
Olomouc 10
Houston 9
Jacksonville 9
Fairfield 8
Redwood City 8
Woodbridge 8
Bandung 7
Boardman 7
Guangzhou 7
Hebei 7
Munich 7
Nanchang 7
Washington 7
Changsha 6
Dallas 6
Dearborn 6
Gragnano 5
Helsinki 5
Kronberg 5
Los Angeles 5
Nola 5
Paris 5
Perugia 5
Pontelandolfo 5
Shenyang 5
Toronto 5
Ann Arbor 4
Calvizzano 4
Delhi 4
Dublin 4
Tianjin 4
Andover 3
Augusta 3
Bari 3
Indiana 3
Lanzhou 3
Magenta 3
Norwalk 3
San Mateo 3
Sciacca 3
Acqui Terme 2
Ancona 2
Avellino 2
Babahoyo 2
Bogotá 2
Bologna 2
Busto Arsizio 2
Cairo 2
Cambridge 2
Casagiove 2
Caserta 2
Castellammare di Stabia 2
Changchun 2
Chiang Mai 2
Comiziano 2
Conversano 2
Genzano di Roma 2
Marigliano 2
Marsala 2
Modena 2
Palermo 2
Pavia 2
Portland 2
Pugliano 2
Reggio Emilia 2
Richmond 2
Romainville 2
San Donato Milanese 2
San Michele Al Tagliamento 2
San Nicola la Strada 2
San Vendemiano 2
Taranto 2
Teverola 2
Torre del Greco 2
Vertova 2
Vietri Sul Mare 2
Volos 2
Totale 1.673
Nome #
Evidence-based directions for polypharmacy revision: The experience gained by the campania reference site in the framework of the eip-aha action group A1 and of the friendd pilot study 94
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 78
Growth hormone deficiency is associated with worse cardiac function, physical performance, and outcome in chronic heart failure: Insights from the T.O.S.CA. GHD study 73
The Italian version of the quick mild cognitive impairment (Qmci-I) screen: normative study on 307 healthy subjects 72
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 71
GH and the cardiovascular system: an update on a topic at heart 67
The Tosca Registry: An Ongoing, Observational, Multicenter Registry for Chronic Heart Failure 66
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 64
Klinefelter syndrome, cardiovascular system, and thromboembolic disease: Review of literature and clinical perspectives 63
Multiple hormone deficiency syndrome in heart failure with preserved ejection fraction 62
Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction 57
Multiple hormone deficiencies in chronic heart failure 55
Bowel Angiodysplasia and Myocardial Infarction secondary to an ischaemic imbalance: A case report 54
Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry 52
Human heart shifts from IGF-1 production to utilization with chronic heart failure 50
Detectable interleukin-9 plasma levels are associated with impaired cardiopulmonary functional capacity and all-cause mortality in patients with chronic heart failure 50
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 49
The T.O.S.CA. Project: research, education and care. 47
Growth Hormone as Biomarker in Heart Failure 47
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 47
Primary prevention of cancer-related thrombosis: special focus on ambulatory patients 45
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 44
Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia 43
IGF-1 predicts survival in chronic heart failure. Insights from the T.O.S.CA. (Trattamento Ormonale Nello Scompenso CArdiaco) registry 42
Biomarkers in Pulmonary Hypertension 40
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 40
Hormone replacement therapy in heart failure 39
Correction to: Human heart shifts from IGF-1 production to utilization with chronic heart failure (Endocrine, (2019), 65, 3, (714-716), 10.1007/s12020-019-01993-y) 39
Anti remodeling therapy: New strategies and future perspective in post-ischemic heart failure. Part II 39
Cardiovascular abnormalities in Klinefelter Syndrome 38
Risk factors for cancer-related venous thromboembolism in ambulatory patients. 38
The GH/IGF-1 axis in chronic heart failure. 37
Hormonal alterations in heart failure: anabolic impairment in chronic heart failure - diagnostic, prognostic and therapeutic issues 37
Pregabalin-induced first degree atrioventricular block in a young patient treated for pain from extrapulmonary tuberculosis 37
Growth Hormone Therapy in Heart Failure 37
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry 37
Gender-related differences in pulmonary arterial hypertension targeted drugs administration 36
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 36
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 36
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 36
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 35
Circulating cell-free DNA levels are associated with adverse outcomes in heart failure: testing liquid biopsy in heart failure 35
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 35
A giant pseudoaneurysm of the forearm as unusual complication of bacterial endocarditis. 33
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 33
Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement: the complexity of the elderly 33
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 32
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study 31
Hormonal Replacement Therapy in Heart Failure: Focus on Growth Hormone and Testosterone 31
Anti remodeling therapy: New strategies and future perspective in post-ischemic heart failure: Part I 31
Combined effects of growth hormone and testosterone replacement treatment in heart failure 31
Postoperative myocardial injury: Trying to square the circle 30
Acute Heart Failure: Diagnostic-Therapeutic Pathways and Preventive Strategies-A Real-World Clinician's Guide 29
Implementing an ICT-Based Polypharmacy Management Program in Italy 29
Testosterone treatment in chronic heart failure. Review of literature and future perspectives 29
Anabolic/catabolic imbalance in chronic heart failure 28
Biomarkers and Imaging: Complementary or Subtractive? 28
Growth hormone replacement delays the progression of chronic heart failure combined with growth hormone deficiency: an extension of a randomized controlled single-blind study. 27
Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry 26
The impairment of the Growth Hormone/Insulin-like growth factor 1 (IGF-1) axis in heart failure: A possible target for future therapy 26
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice 25
An unusual case of dilated cardiomyopaty associated with partial hypopituitarism. 24
Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer 23
Early Left Ventricular Diastolic Dysfunction in Females with Chronic Hyperprolactinemia: A Doppler Echocardiographic Study 22
Exploring the Cardiotoxicity Spectrum of Anti-Cancer Treatments: Definition, Classification, and Diagnostic Pathways 21
Pulmonary arterial hypertension-related myopathy: An overview of current data and future perspectives 21
Heart failure management during the COVID-19 outbreak in Italy: a telemedicine experience from a heart failure university tertiary referral centre 21
What have we learned so far from the sex/gender issue in heart failure? An overview of current evidence 19
The impact of gender in cardiovascular medicine: Lessons from the gender/sex-issue in heart failure 19
Bowel Angiodysplasia and Myocardial Infarction secondary to an ischaemic imbalance: a case report 18
GH deficiency in mild-to-moderate chronic heart failure is associated to worse clinical status, cardiopulmonary performance, and LV remodeling 17
Identification of Drugs Acting as Perpetrators in Common Drug Interactions in a Cohort of Geriatric Patients from Southern Italy and Analysis of the Gene Polymorphisms That Affect Their Interacting Potential 17
Metabolic Syndrome in Heart Failure: Friend or Foe? 17
Insulin-like growth factor-1 (IGF-1) as predictor of cardiovascular mortality in heart failure patients: data from the T.O.S.CA. registry 16
Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction 14
Hormonal alterations in heart failure: anabolic impairment in chronic heart failure - diagnostic, prognostic and therapeutic issues 14
Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry 14
Cardiovascular Side Effects of Anthracyclines and HER2 Inhibitors among Patients with Breast Cancer: A Multidisciplinary Stepwise Approach for Prevention, Early Detection, and Treatment 13
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 13
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 13
The role of curcumin in liver diseases 12
Cardiovascular abnormalities in the Low IGF-1 Syndrome: insights from the TOSCA project 11
Detectable plasma levels of Interleukin-9 are associated with impaired exercise capacity and poor outcomes in Chronic Heart Failure and reduced ejection fraction 9
Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation 8
Clinical and non-clinical determinants of pulmonary arterial hypertension development in severe autoimmune rheumatic diseases 7
The dual relationship between polypharmacy and frailty in nursing home residents: polypharmacy as a cause or a consequence? 7
Detectable plasma levels of interleukin-9 are associated with impaired exercise capacity and poor survival in chronic heart failure 5
Beneficial Effects on Exercise Capacity Associated with a Combination of Lactoferrin, Lysozyme, Lactobacillus, Resveratrol, Vitamins, and Oligoelements in Patients with Post-COVID-19 Syndrome: A Single-Center Retrospective Study 3
Totale 3.029
Categoria #
all - tutte 15.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.338


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020130 0 0 0 0 14 15 2 8 10 31 38 12
2020/2021266 67 13 14 18 18 23 12 16 33 12 14 26
2021/2022448 9 6 12 4 8 9 8 11 41 52 130 158
2022/2023763 68 44 26 31 92 83 27 68 137 121 53 13
2023/2024647 27 81 93 60 37 79 23 90 9 15 76 57
2024/2025393 144 118 19 55 57 0 0 0 0 0 0 0
Totale 3.029